Register
Upcoming Conference
San Diego, December 2, 2021

OHA says as many as 300,000 enrollees may come off the Oregon Health Plan once the public health emergency ends

| Oct 28, 2021 | Oregon

The Oregon Health Authority (OHA) estimates as many as 300,000 Medicaid enrollees may be taken off the Oregon Health Plan once the federal public health emergency (PHE) ends. Medicaid eligibility redeterminations have mostly been on hold during the pandemic, but the lengthy process could begin as soon as January 2022...[ Read More ]

5 Things Washington: Medicaid redetermination, COVID-19 treatment costs, Women & children's health report

| Oct 28, 2021 | Washington

We've been hard at work putting together the Topical Agenda for the 2022 Washington State of Reform Health Policy Conference coming up on January 6. We'll announce that agenda in the coming weeks, but if you already know that you want to join us, be sure to take advantage of the Early Bird...[ Read More ]

5 Things Maryland: Health equity RFP, Bending the Rx cost curve, Oral health task force

| Oct 28, 2021 | Maryland

In case you missed it, registration is now open for our "5 Slides: Bending the Rx cost curve" virtual conversation. It will be an interactive conversation on a topic that continues to be top of mind for lawmakers and stakeholders. More details on the discussion are available below. In this...[ Read More ]

5 Things Virginia: Q&A w/ Dr. Danny TK Avula, Bending the Rx cost curve, Medicaid redetermination

| Oct 27, 2021 | Virginia

The general election is right around the corner. With that in mind, State of Reform reached out to several health policy leaders in Virginia for a conversation on how the results might impact health policy in the state. More on that below. This edition of "5 Things We're Watching" also...[ Read More ]

Leadership Series: The future of gene therapy

| Oct 25, 2021 | Federal

Bhash Parasuraman, vice president of value and access for rare disease and internal medicine at Pfizer, joined State of Reform on Thursday for a conversation on the future of gene therapy.  As part of our virtual “Leadership Series,” Parasuraman discussed the outlook for gene therapy, the policies she’d like to...[ Read More ]

OHA releases draft rules for new “Health Care Market Oversight Program”

| Oct 22, 2021 | Oregon

The Oregon Health Authority (OHA) this week posted draft rules for the implementation of House Bill 2362 – a bill passed this year requiring health care entities to obtain approval from OHA for certain mergers, acquisitions, or affiliation transactions. OHA posted the draft rules on Monday in preparation for its...[ Read More ]

Get the latest state-specific policy intelligence for the health care sector delivered to your inbox.